Search
Search
Cell therapy manufacturing demands tightly controlled, closed-system liquid handling across T cell isolation, processing, storage, and transfer steps. Open processing steps can introduce the risk of microbial contamination, loss of cell viability, and batch failure that can compromise program timelines.
CTS single-use kit assemblies are designed to integrate directly with automated CTS instruments and support cGMP-compliant manufacturing environments. Unlike general-purpose bags, CTS kit assemblies specifically support T cell workflows by reducing manual interventions and enabling contamination control within an integrated workflow.
Cell therapy kits and assemblies offer performance and quality advantages compared to open or non-integrated alternatives.
Kit assemblies with bags are used across multiple stages of the T cell manufacturing workflow. The assemblies support upstream processing (USP), including initial cell isolation from leukapheresis or whole blood material, as well as subsequent steps such as magnetic bead removal. Consistent use of compatible single-use assemblies across stages can help reduce variability between steps.
Cell therapy products can help teams reduce open handling steps, maintain process consistency, and build toward a cGMP-ready manufacturing platform.
For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.